A breakthrough advance that turns conventional wisdom on its head could lead to a simple blood test for Alzheimer's, research has shown.
The same technology, successfully tested on human patients, could make it easier to spot hard-to-detect cancers and other diseases.
It involves using synthetic molecules called peptoids to “fish” for disease-specific antibodies in the blood, said Professor Thomas Kodadek, from Scripps Research Institute in California, who led the research.
COMMENT RULES: Comments that are judged to be defamatory, abusive or in bad taste are not acceptable and contributors who consistently fall below certain criteria will be permanently blacklisted. The moderator will not enter into debate with individual contributors and the moderator’s decision is final. It is Belfast Telegraph policy to close comments on court cases, tribunals and active legal investigations. We may also close comments on articles which are being targeted for abuse. Problems with commenting? email@example.com